860 filings
Page 25 of 43
424B2
w7uhn5ygkw42s
9 Mar 18
Prospectus for primary offering
12:00am
424B2
60rjn
9 Mar 18
Prospectus for primary offering
12:00am
EFFECT
8kpcyd o8rv83
7 Mar 18
Notice of effectiveness
12:00am
CORRESP
h52gn4e
5 Mar 18
Correspondence with SEC
12:00am
UPLOAD
6in3k3nszkwdmpn28w
2 Mar 18
Letter from SEC
12:00am
D/A
265cftb kc3se43lf65j
28 Feb 18
$17.64M in equity / options / securities to be acquired, sold $17.64M, 200 investors
12:00am
SC TO-I/A
68xl4g wg
28 Feb 18
Issuer tender offer statement (amended)
12:00am
8-K
avp4 k4ytsdt9yeg
20 Feb 18
CytoDyn Reports Primary Endpoint Achieved in PRO 140 Pivotal Combination
12:00am
SC TO-I/A
fiklv4o qt
20 Feb 18
Issuer tender offer statement (amended)
12:00am
SC TO-I/A
n3wd0tv
20 Feb 18
Issuer tender offer statement (amended)
12:00am
8-K
h4q0gup
20 Feb 18
Entry into a Material Definitive Agreement
12:00am
SC TO-I/A
m81wpj16ts 5gm3h
14 Feb 18
Issuer tender offer statement (amended)
12:00am
8-K
eg3f15nd6lx7wl9ni1
13 Feb 18
Departure of Directors or Certain Officers
12:00am
SC TO-I/A
9gme85u12 8zbgrmj2
7 Feb 18
Issuer tender offer statement (amended)
12:00am
8-K
5cqahy2gd5 z3h
7 Feb 18
Entry into a Material Definitive Agreement
12:00am
SC TO-I/A
c0whlxrxq9dkv2
31 Jan 18
Issuer tender offer statement (amended)
12:00am
8-K
toq4sppjymxs
31 Jan 18
Entry into a Material Definitive Agreement
12:00am
424B5
bnnb1g207x783gdejk31
31 Jan 18
Prospectus supplement for primary offering
12:00am